BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 3970836)

  • 1. Serial liver biopsies in psoriatic patients receiving long-term etretinate.
    Roenigk HH; Gibstine C; Glazer S; Sparberg M; Yokoo H
    Br J Dermatol; 1985 Jan; 112(1):77-81. PubMed ID: 3970836
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Ultrastructural survey and tissue analysis of human livers after a 6-month course of etretinate.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M; Paravicini U
    J Am Acad Dermatol; 1984 Apr; 10(4):632-8. PubMed ID: 6715613
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A study of potential hepatotoxicity of etretinate used in the treatment of psoriasis.
    Glazer SD; Roenigk HH; Yokoo H; Sparberg M
    J Am Acad Dermatol; 1982 Apr; 6(4 Pt 2 Suppl):683-7. PubMed ID: 7068976
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Histologic changes in the liver during etretinate treatment.
    Foged E; Bjerring P; Kragballe K; Søgaard H; Zachariae H
    J Am Acad Dermatol; 1984 Oct; 11(4 Pt 1):580-3. PubMed ID: 6490982
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Bone mineral density of the lumbar spine in psoriatic patients with long term etretinate therapy.
    Okada N; Nomura M; Morimoto S; Ogihara T; Yoshikawa K
    J Dermatol; 1994 May; 21(5):308-11. PubMed ID: 8051315
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Successful use of isotretinoin in type Zumbusch generalized pustular psoriasis following recovered etretinate-induced hepatitis].
    Marhold I; Duschet P; Schwarz T; Gschnait F
    Hautarzt; 1991 Sep; 42(9):580-3. PubMed ID: 1938411
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Long-term effects of etretinate on the liver in psoriasis.
    Camuto P; Shupack J; Orbuch P; Tobias H; Sidhu G; Feiner H
    Am J Surg Pathol; 1987 Jan; 11(1):30-7. PubMed ID: 3789256
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Joint pains with psoriasis and long-term systemic etretinate therapy: a case report and summary of 12 cases.
    Ishida Y; Ozawa A; Ohkido M; Imai N
    J Dermatol; 1993 Oct; 20(10):651-3. PubMed ID: 8277044
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The safety of etretinate as long-term therapy for psoriasis: results of the etretinate follow-up study.
    Stern RS; Fitzgerald E; Ellis CN; Lowe N; Goldfarb MT; Baughman RD
    J Am Acad Dermatol; 1995 Jul; 33(1):44-52. PubMed ID: 7601945
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Etretinate therapy for psoriasis: clinical responses, remission times, epidermal DNA and polyamine responses.
    Kaplan RP; Russell DH; Lowe NJ
    J Am Acad Dermatol; 1983 Jan; 8(1):95-102. PubMed ID: 6826812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Isotretinoin vs etretinate therapy in generalized pustular and chronic psoriasis.
    Moy RL; Kingston TP; Lowe NJ
    Arch Dermatol; 1985 Oct; 121(10):1297-301. PubMed ID: 3862363
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Association of etretinate and fish oil in psoriasis therapy. Inhibition of hypertriglyceridemia resulting from retinoid therapy after fish oil supplementation.
    Frati C; Bevilacqua L; Apostolico V
    Acta Derm Venereol Suppl (Stockh); 1994; 186():151-3. PubMed ID: 8073820
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Curling and kinking of hair caused by etretinate].
    Schauder S; Tsambaos D; Nikiforidis G
    Hautarzt; 1992 Aug; 43(8):509-13. PubMed ID: 1506218
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Clinical experience with etretinate (Tigason) in 26 patients with psoriasis].
    Gajardo J
    Rev Med Chil; 1989 May; 117(5):516-22. PubMed ID: 2519162
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Treatment of psoriatic arthropathy with etretinate: a two-year follow-up.
    Chieregato GC; Leoni A
    Acta Derm Venereol; 1986; 66(4):321-4. PubMed ID: 2430403
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Short-term etretinate for pustular psoriasis.
    Rubin MG; Hanno R
    J Am Acad Dermatol; 1985 May; 12(5 Pt 1):896-7. PubMed ID: 4008697
    [No Abstract]   [Full Text] [Related]  

  • 17. [Unusual side effects in patients with psoriatic erythroderma treated with etretinate (RO 10-9359)].
    Castel T; Castro J; Lecha M; Mascaró JM
    Med Cutan Ibero Lat Am; 1986; 14(2):83-6. PubMed ID: 2943953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Combination of etretinate and dithrocream for severe psoriasis].
    Vardy D; Werner E
    Harefuah; 1988 Apr; 114(7):342-4. PubMed ID: 3371786
    [No Abstract]   [Full Text] [Related]  

  • 19. Comparison of etretinate (Tigason) and parenteral gold in the treatment of psoriatic arthropathy.
    Seppälä J; Laulainen M; Reunala T
    Clin Rheumatol; 1988 Dec; 7(4):498-503. PubMed ID: 3149925
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A double-blind controlled trial of etretinate (Tigason) and ibuprofen in psoriatic arthritis.
    Hopkins R; Bird HA; Jones H; Hill J; Surrall KE; Astbury C; Miller A; Wright V
    Ann Rheum Dis; 1985 Mar; 44(3):189-93. PubMed ID: 3883917
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.